Abstract
US demand to rise more than 17% annually thru 2014
US demand for nanotechnology medical products will rise more than 17 percent
per year to $75.1 billion in 2014. Going forward, the increasing flow of new
nanomedicines, nanodiagnostics, and nanotech- based medical supplies and
devices into the US marketplace will boost demand to $149 billion in 2019.
Nanomedicine market to reach $59 billion in 2014
The total market for nanomedicines will command strong growth over the long
term, rising to almost $59 billion in 2014 and sustaining a strong upward pace
through 2019. Treatments based on humanized monoclonal antibodies,
nanopolymers and nanoproteins will drive gains, with compounds for cancer,
heart diseases, neurological disorders and viral infections leading new
product introductions and growth opportunities. Eventually, nanomedicines will
extend into all major therapeutic classes, encompassing numerous formulations
and delivery systems.
Nanodiagnostic products to grow nearly 7% annually
Among nanodiagnostic products, nanosized monoclonal antibody labels and DNA
probes are greatly enhancing the speed, accuracy, capabilities and
costeffectiveness of in vitro diagnostic testing, drug discovery and medical
research procedures. Nanoparticle formulations of superparamagnetic iron
oxide, gadolinium, perfluorocarbon and specialty polymers will broaden in vivo
imaging capabilities by enabling the detection of tumors, plaque, genetic
defects and other disease states at much earlier stages and with lower, safer
concentrations of injected compounds. Reflecting anticipated performance
advantages over existing products and an expanding range of new commercial
offerings, demand for nanodiagnostics is projected to increase 6.8 percent per
year to $11.3 billion in 2014, and continue rising at a good pace through 2019.
Nanotech supplies, devices to reach $5.1 billion in 2014
Within the medical supplies and devices segment, nanomaterials are already
gaining significant demand as active ingredients of burn dressings, bone
substitutes, and dental repair and restoration products. In the long term,
advances in nanotechnology will lead to the introduction of new, improved
medical supply and device coatings as well as a new, diverse group of medical
implants. In 2014, demand for medical supplies and devices based at least
partially on nanomaterials is projected to reach $5.1 billion, up from $530
million in 2009. This amount will more than triple by 2019 as
nanotechnology-based orthopedic and cardiac implants and nanocoated medical
and surgical instruments penetrate the marketplace.
Cancer among first disorders treated by nanotechnology
The greatest near-term impact of nanotechnology in health care by indication
will be in therapies and diagnostics for cancer and central nervous system
disorders. Gradually, many other major diseases, as well as injuries, will be
treated and detected routinely by products based on nanosized ingredients. The
nanotechnology segment of the medical product industry is divided among large
multinational drug and medical supply companies, and research-oriented firms
that develop commercial products or nanomaterials.
Study coverage
This new Freedonia industry study, Nanotechnology in Health Care, presents
historical demand data plus forecasts for 2014 and 2019 by product type and
application. The study also considers recent health insurance reforms and
overall drug and medical device regulatory trends, evaluates company market
share and profiles participants in the US industry.
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Trends
- Demographic Patterns
- Trends in Health Care
- Health Insurance & Reimbursement
- Medical Conditions
- Chronic Conditions
- Acute Conditions
- National Health Expenditures
- Medical Facilities & Professionals
- Acute Care Hospitals
- Physicians
- Outpatient Facilities
- Skilled Nursing Homes
- Dentists
- Patient Activity
- Hospital Activity
- Surgical Procedures
- Outpatient Activity
- Diagnostic Tests
- Medical Products Market Outlook
- Pharmaceuticals & Biologicals
- Surgical Appliances & Supplies
- Surgical & Medical Instruments
- Electromedical Equipment
- Diagnostic Products
- Other Medical Products
III. MEDICAL NANOMATERIALS
- General
- Monoclonal Antibodies
- Drug Nanoparticles
- DNA Materials
- Quantum Dots
- Other Medical Nanomaterials
- Commercialized Materials
- Dendrimers
- Fullerenes
- Nanotubes & Nanowires
IV. NANOTECHNOLOGY HEALTH CARE OVERVIEW
- General
- Product Applications
- Regulation
- Pharmaceuticals
- Diagnostic Products
- Medical Supplies & Devices
- Current Good Manufacturing Processes
- Investment
- US Trade Opportunities
- International Activities
V. NANOMEDICINES
- General
- Monoclonal Antibodies
- Types of Monoclonal Antibodies
- Marketed Products
- Developmental Activities
- Nanopolymer Medicines
- Marketed Products
- PEG-Based Nanomedicines
- Other Nanopolymer Medicines
- Developmental Activities
- Crystalline Nanomedicines
- Marketed Products
- Developmental Activities
- Liposomal Nanomedicines
- Marketed Products
- Developmental Activities
- Other Nanomedicines
- Marketed Products
- Developmental Activities
VI. NANODIAGNOSTICS
- General
- In Vitro Nanodiagnostics
- Monoclonal Antibody-Based Nanodiagnostics
- Immunological Reagents
- Cellular Analysis Reagents
- Immunohematology Reagents
- Research Reagents
- DNA-Based Nanodiagnostics
- Amplified DNA Probes
- Direct DNA Probes
- DNA Microarrays
- Other DNA-Based Nanodiagnostics
- In Vivo Nanodiagnostics
- MRI Imaging Agents
- Marketed Products
- Developmental Products
- Other In Vivo Nanodiagnostics
VII. NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES
- General
- Wound Management Products
- Wound Dressings
- Wound Closures
- Bone Substitutes
- Dental Products
- Surgical Supplies & Devices
- Surgical Textiles
- Surgical Devices
- Medical Implants
- Orthopedic Implants
- Cardiac Implants
- Cochlear Implants
- Other Medical Implants
- Ophthalmic Products
- Nanocoated Lenses
- Drug Delivery Systems
- Retinal Implants
- Other Nanotechnology Medical Supplies & Devices
- Catheters & Related Devices
- Disinfectants
- Artificial Skin
VIII. APPLICATIONS
- General
- Cancer
- Epidemiological Trends
- Nanomedicines
- Nanodiagnostics
- Nanotechnology Medical Supplies & Devices
- Central Nervous System Conditions
- Epidemiological Trends
- Nanomedicines
- Nanodiagnostics
- Nanotechnology Medical Supplies & Devices
- Infective Conditions
- Epidemiological Trends
- Nanomedicines
- Nanodiagnostics
- Nanotechnology Medical Supplies & Devices
- Cardiovascular Conditions
- Epidemiological Trends
- Nanomedicines
- Nanodiagnostics
- Nanotechnology Medical Supplies & Devices
- Other Applications
- Ophthalmic Conditions
- Medical Research & Drug Discovery
- Respiratory Conditions
- Endocrine Conditions
- Gastrointestinal Conditions
- Dermatological Conditions
- All Other Applications
IX. INDUSTRY STRUCTURE
- General
- Market Share
- Competitive Strategies
- Licensing Agreements
- Mergers & Acquisitions
- Research & Development
- Marketing & Distribution
- Manufacturing
COMPANY PROFILES
- Abbott Laboratories
- Abraxis BioScience Incorporated
- Access Pharmaceuticals Incorporated
- Advion BioSciences Incorporated
- Alexion Pharmaceuticals Incorporated
- AMAG Pharmaceuticals Incorporated
- Amgen Incorporated
- Arrowhead Research Corporation
- AstraZeneca plc
- Bayer AG
- BIOCIUS Life Sciences Incorporated
- Biogen Idec Incorporated
- Biophan Technologies Incorporated
- BioTrove, see Life Technologies
- Bristol-Myers Squibb Company
- Calando Pharmaceuticals, see Arrowhead Research
- Centocor Ortho Biotech Products, see Johnson & Johnson
- Covidien plc
- CritiTech Incorporated
- Crystalplex Corporation
- CytImmune Sciences Incorporated
- Danaher Corporation
- Dendritic Nanotechnologies, see Starpharma Holdings
- Elan Corporation plc
- Enzon Pharmaceuticals Incorporated
- Flamel Technologies SA
- Genentech, see Roche Holding
- GlaxoSmithKline plc
- ImClone Systems, see Lilly (Eli) and Company
- Intradigm, see Silence Therapeutics
- Johnson & Johnson
- Kerr, see Danaher
- Life Technologies Corporation
- Lilly (Eli) and Company
- Luna Innovations Incorporated
- Merck & Company Incorporated
- Mersana Therapeutics Incorporated
- NanoBio Corporation
- Nanobiotix SA
- NanoCarrier Company Limited
- NanoDel Technologies GmbH
- NanoHorizons Incorporated
- NanoInk Incorporated
- NanoLab Incorporated
- Nanospectra Biosciences Incorporated
- Nanosys Incorporated
- Nektar Therapeutics Incorporated
- Novagali Pharma SA
- Novartis AG
- Novavax Incorporated
- Orthovita Incorporated
- Oxonica plc
- Pfizer Incorporated
- Pioneer Surgical Technology Incorporated
- pSivida Corporation
- Roche Holding Limited
- Salvona Technologies Incorporated
- Schering-Plough, see Merck & Company
- Sensatex Incorporated
- Siemens AG
- SkyePharma plc
- Smith & Nephew plc
- Soliqs, see Abbott Laboratories
- Spectrum Pharmaceuticals Incorporated
- Starpharma Holdings Limited
- Tego Biosciences, see Arrowhead Research
- Teva Pharmaceutical Industries Limited
- 3M Company
- Wyeth, see Pfizer
- Other Companies Mentioned in the Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Resident Population by Age Group
- 3 Health Insurance Coverage of the US Population
- 4 Chronic Conditions by Type
- 5 Acute Conditions by Type
- 6 National Health Expenditures
- 7 Selected Medical Facilities & Professionals by Type
- 8 Patient Activity by Type
- 9 Medical Products Demand by Group
SECTION III -- MEDICAL NANOMATERIALS
- 1 Medical Nanomaterials Demand by Type
SECTION IV -- NANOTECHNOLOGY HEALTH CARE OVERVIEW
- 1 Nanotechnology Medical Products Demand by Group
- 2 US Trade in Nanotechnology Medical Products
- 3 World Demand for Nanotechnology Medical Products by Region
SECTION V -- NANOMEDICINES
- 1 Nanomedicines Demand by Product Group
- 2 Monoclonal Antibody Nanomedicines Demand by Indication
- 3 Therapeutic Monoclonal Antibodies Approved for US Sale
- 4 US Sales of Selected Therapeutic Monoclonal Antibodies, 2004 & 2009
- 5 Nanopolymer Medicines Demand by Indication
- 6 Polymer Nanomedicines Approved for US Sale
- 7 US Sales of Nanopolymer Medicines, 2004 & 2009
- 8 Crystalline Nanomedicines Demand by Indication
- 9 Crystalline Nanomedicines Approved for US Sales
- 10 Liposomal Nanomedicines Demand by Indication
- 11 Other Nanomedicines Demand by Indication
SECTION VI -- NANODIAGNOSTICS
- 1 Nanodiagnostics Demand by Product Group
- 2 In Vitro Nanodiagnostics Demand by Product Group
- 3 Monoclonal Antibody-Based Nanodiagnostics Demand by Type
- 4 Monoclonal Antibody-Based Immunological Reagents Demand
- 5 Monoclonal Antibody-Based Cellular Analysis Reagents Demand
- 6 Monoclonal Antibody Immunohematology Reagents Demand
- 7 Monoclonal Antibody-Based Research Reagents Demand
- 8 DNA-Based Nanodiagnostics Demand by Type
- 9 In Vivo Nanodiagnostics Demand by Product Group
SECTION VII -- NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES
- 1 Nanotechnology Medical Supplies & Devices Demand by Product Group
- 2 Nanotechnology Wound Management Products Demand by Type
- 3 Nanotechnology Bone Substitutes Demand
- 4 Nanotechnology Dental Products Demand by Group
- 5 Nanotechnology Surgical Supplies & Devices Demand
- 6 Nanotechnology Medical Implant Demand by Type
- 7 Nanotechnology Ophthalmic Products
- 8 Other Nanotechnology Medical Supplies & Devices
SECTION VIII -- APPLICATIONS
- 1 Nanotechnology Medical Products Demand by Application
- 2 Nanotechnology Medical Products Demand in Cancer Applications
- 3 Nanotechnology Medical Products Demand in Central Nervous System (CNS)
Applications
- 4 Nanotechnology Medical Products Demand in Infective Condition
Applications
- 5 Nanotechnology Medical Products Demand in Cardiovascular Applications
- 6 Nanotechnology Medical Products Demand in Other Applications
SECTION IX -- INDUSTRY STRUCTURE
- 1 US Nanotechnology Medical Product Sales by Company, 2009
- 2 Selected Cooperative Agreements
- 3 Selected Acquisitions & Divestitures
LIST OF CHARTS
SECTION II -- MARKET ENVIRONMENT
- Medical Products Demand by Group, 2009
SECTION III -- MEDICAL NANOMATERIALS
- Medical Nanomaterials Demand by Type, 2009
SECTION IV -- NANOTECHNOLOGY HEALTH CARE OVERVIEW
- Nanotechnology Medical Products Demand by Group, 2009
SECTION V -- NANOMEDICINES
- Nanomedicines Demand by Product Group, 2009
SECTION VI -- NANODIAGNOSTICS
- Nanodiagnostics Demand by Product Group, 2009
SECTION VII -- NANOTECHNOLOGY MEDICAL SUPPLIES & DEVICES
- Nanotechnology Medical Supplies & Devices Demand by Product Group, 2014
SECTION VIII -- APPLICATIONS
- Nanotechnology Medical Products Demand by Application, 2009
SECTION IX -- INDUSTRY STRUCTURE
- Nanotechnology Medical Products Market Share by Company, 2009
